Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE)

Ingmar Skoog; Hans Lithell; Lennart Hansson; Dag Elmfeldt; Albert Hofman; Bertil Olofsson; Peter Trenkwalder; Alberto Zanchetti

doi:10.1016/j.amjhyper.2005.02.013

Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE)

Ingmar Skoog, Hans Lithell, Lennart Hansson, Dag Elmfeldt, Albert Hofman, Bertil Olofsson, Peter Trenkwalder, Alberto Zanchetti

Fondazione Istituto Auxologico Italiano

Research output: Contribution to journal › Article › peer-review

Abstract

Background: We examined whether cognitive function at baseline affected cognitive and cardiovascular outcomes in the Study on COgnition and Prognosis in the Elderly (SCOPE), a blood pressure (BP)-lowering intervention trial. Methods: SCOPE included 4937 patients, aged 70 to 89 years, with mild-to-moderate hypertension and Mini Mental State Examination (MMSE) score

Original language	English
Pages (from-to)	1052-1059
Number of pages	8
Journal	American Journal of Hypertension
Volume	18
Issue number	8
DOIs	https://doi.org/10.1016/j.amjhyper.2005.02.013
Publication status	Published - Aug 2005

Keywords

Candesartan
Cognitive function
Elderly
Hypertension
Outcomes

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.amjhyper.2005.02.013

Cite this

Skoog, I., Lithell, H., Hansson, L., Elmfeldt, D., Hofman, A., Olofsson, B., Trenkwalder, P., & Zanchetti, A. (2005). Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE). American Journal of Hypertension, 18(8), 1052-1059. https://doi.org/10.1016/j.amjhyper.2005.02.013

Skoog, I, Lithell, H, Hansson, L, Elmfeldt, D, Hofman, A, Olofsson, B, Trenkwalder, P & Zanchetti, A 2005, 'Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE)', American Journal of Hypertension, vol. 18, no. 8, pp. 1052-1059. https://doi.org/10.1016/j.amjhyper.2005.02.013

@article{058d8ed08e294098acfddc2a36d6bee7,

title = "Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE)",

abstract = "Background: We examined whether cognitive function at baseline affected cognitive and cardiovascular outcomes in the Study on COgnition and Prognosis in the Elderly (SCOPE), a blood pressure (BP)-lowering intervention trial. Methods: SCOPE included 4937 patients, aged 70 to 89 years, with mild-to-moderate hypertension and Mini Mental State Examination (MMSE) score ",

keywords = "Candesartan, Cognitive function, Elderly, Hypertension, Outcomes",

author = "Ingmar Skoog and Hans Lithell and Lennart Hansson and Dag Elmfeldt and Albert Hofman and Bertil Olofsson and Peter Trenkwalder and Alberto Zanchetti",

year = "2005",

month = aug,

doi = "10.1016/j.amjhyper.2005.02.013",

language = "English",

volume = "18",

pages = "1052--1059",

journal = "American Journal of Hypertension",

issn = "0895-7061",

publisher = "Oxford University Press",

number = "8",

}

TY - JOUR

T1 - Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes

T2 - Study on COgnition and Prognosis in the Elderly (SCOPE)

AU - Skoog, Ingmar

AU - Lithell, Hans

AU - Hansson, Lennart

AU - Elmfeldt, Dag

AU - Hofman, Albert

AU - Olofsson, Bertil

AU - Trenkwalder, Peter

AU - Zanchetti, Alberto

PY - 2005/8

Y1 - 2005/8

N2 - Background: We examined whether cognitive function at baseline affected cognitive and cardiovascular outcomes in the Study on COgnition and Prognosis in the Elderly (SCOPE), a blood pressure (BP)-lowering intervention trial. Methods: SCOPE included 4937 patients, aged 70 to 89 years, with mild-to-moderate hypertension and Mini Mental State Examination (MMSE) score

AB - Background: We examined whether cognitive function at baseline affected cognitive and cardiovascular outcomes in the Study on COgnition and Prognosis in the Elderly (SCOPE), a blood pressure (BP)-lowering intervention trial. Methods: SCOPE included 4937 patients, aged 70 to 89 years, with mild-to-moderate hypertension and Mini Mental State Examination (MMSE) score

KW - Candesartan

KW - Cognitive function

KW - Elderly

KW - Hypertension

KW - Outcomes

UR - http://www.scopus.com/inward/record.url?scp=23744468024&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23744468024&partnerID=8YFLogxK

U2 - 10.1016/j.amjhyper.2005.02.013

DO - 10.1016/j.amjhyper.2005.02.013

M3 - Article

C2 - 16109319

AN - SCOPUS:23744468024

VL - 18

SP - 1052

EP - 1059

JO - American Journal of Hypertension

JF - American Journal of Hypertension

SN - 0895-7061

IS - 8

ER -

Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE)

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this